Últimas noticias sobre Equifax (NYSE:EFX) Bolsa

EQUIFAX INC

Equifax

Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States. Equifax's credit reports provide credit histories on millions of consumers, and the firm's services are critical to lenders' credit decisions. In addition, over 40% of the firm's revenue comes from workforce solutions, which provides income verification and employer human resources services. Equifax generates just over 20% of its revenue from outside the United States.

Equifax Inc

Effect Network

Enerflex Ltd

Citigroup analyst Arthur Truslove maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Buy and lowers the price target from $294 to $290.

News

Price Target

Analyst Ratings

Citigroup Maintains Buy on Equifax, Lowers Price Target to $290

UBS analyst Kevin Mcveigh maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Buy and lowers the price target from $315 to $278.

UBS Maintains Buy on Equifax, Lowers Price Target to $278

Oppenheimer analyst Owen Lau maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Outperform and lowers the price target from $296 to $279.

Oppenheimer Maintains Outperform on Equifax, Lowers Price Target to $279

BMO Capital analyst Jeffrey Silber maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Market Perform and lowers the price target from $280 to $260.

BMO Capital Maintains Market Perform on Equifax, Lowers Price Target to $260

JP Morgan analyst Andrew Steinerman maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Overweight and lowers the price target from $277 to $272.

JP Morgan Maintains Overweight on Equifax, Lowers Price Target to $272

Wells Fargo analyst Jason Haas maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Overweight and lowers the price target from $310 to $300.

Wells Fargo Maintains Overweight on Equifax, Lowers Price Target to $300

Baird analyst Jeffrey Meuler maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Outperform and lowers the price target from $310 to $289.

Baird Maintains Outperform on Equifax, Lowers Price Target to $289

Barclays analyst Manav Patnaik maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Equal-Weight and lowers the price target from $260 to $240.

Barclays Maintains Equal-Weight on Equifax, Lowers Price Target to $240

It was a quiet Tuesday on Wall Street, as major indexes edged lower with investors pausing ahead of a critical <a href="https://www.benzinga.com/topic/magnificent-seven">wave of tech earnings.</a>
By midday trading in New York, the S&amp;P 500 dipped 0.1% and the Nasdaq 100 slipped 0.5%, pulling back after hitting fresh all-time highs on Monday. The Russell 2000 outperformed, rising 0.6%.
Weak corporate results weighed on sentiment. Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) plunged 9.5% after missing revenue forecasts. Lockheed Martin Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) dropped more than 8% on a double miss, and General Motors Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) lost 5.5% after warning of a steeper-than-expected tariff hit in the second half of 2025.
Health care led sector gains, while tech stocks lagged, as attention turns to earnings from Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), and Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) which are slated to report earnings on Wednesday. 
On the macro front, Treasury Secretary Scott Bessent said the U.S. will meet with Chinese officials next week to continue trade negotiations. That raised hopes for an extension to the August 12 China tariff deadline.
In the bond market, the 10-year Treasury yield fell for a fifth straight session to 4.33%, its lowest level in over a week. Meanwhile, the U.S. dollar index dropped 0.4%, extending its slide for a third day.
Gold climbed 0.9% to $3,420 per ounce, the highest since June 16, as uncertainty surrounding the Federal Reserve's independence and Chair Jerome Powell's future fueled safe-haven demand.
In crypto, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) rose 1.4% to $119,000, extending its rebound alongside broader market hedging flows.
Read also:<a href="https://www.benzinga.com/markets/macro-economic-events/25/07/46549915/el-erian-powell-trump-resign-fed-independence-scott-bessent"> El-Erian Says Powell Should Resign—To Save The Fed Itself</a>
<h3 class="wp-block-heading">Tuesday&#8217;s Performance Of Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,243.42</td>
<td>0.6%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>44,378.27</td>
<td>0.1%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>6,300.18</td>
<td>-0.1%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>23,073.22</td>
<td>-0.5%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated by 12:00 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul class="wp-block-list">
<li>The&nbsp;Vanguard S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOO#NYSE">VOO</a>) eased 0.2% to $557.08.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) flattened at $443.63.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;eased 0.6% to $560.86.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) rose 0.6% at $222.67.</li>
<li>The&nbsp;Health Care&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>) outperformed, up 1.3%; the&nbsp;Technology&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) lagged, down 0.7%.</li>
</ul>
<h3 class="wp-block-heading">Tuesday&#8217;s Stock Movers</h3>
Stocks reacting on earnings reports included: 
<ul class="wp-block-list">
<li>D.R. Horton Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>), up 14.5%</li>
<li>Northrop Grumman Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>), up 8.4%</li>
<li>PACCAR Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCAR#NASDAQ">PCAR</a>), up 4.7%</li>
<li>MSCI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>), down 6.8%</li>
<li>RTX Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>), down 2.5%</li>
<li>Coca-Cola Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>), down 1.0%</li>
<li>Danaher Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>), down 0.3%</li>
<li>Equifax Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>), down 7.2%</li>
<li>IQVIA Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IQV#NYSE">IQV</a>) up 18%, </li>
<li>Synchrony Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYF#NYSE">SYF</a>) up 1.5%</li>
<li>PulteGroup Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHM#NYSE">PHM</a>) up 9.4%</li>
<li>KeyCorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEY#NYSE">KEY</a>) up 1.6%</li>
<li>Quest Diagnostics Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DGX#NYSE">DGX</a>) up 6.3%</li>
<li>Halliburton Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAL#NYSE">HAL</a>) up 0.4%</li>
<li>Genuine Parts Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPC#NYSE">GPC</a>) up 5.5%</li>
<li>Tenet Healthcare Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) down 4.3%</li>
<li>Avery Dennison Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVY#NYSE">AVY</a>) up 0.3%</li>
<li>Invesco Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVZ#NYSE">IVZ</a>) up 4.1%</li>
<li>Mueller Industries Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLI#NYSE">MLI</a>) up 0.5%</li>
<li>Old National Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONB#NASDAQ">ONB</a>) down 1.2%</li>
<li>Valmont Industries Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VMI#NYSE">VMI</a>) up 5.1%</li>
<li>Badger Meter Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMI#NYSE">BMI</a>) down 13.8% </li>
<li>Medpace Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDP#NASDAQ">MEDP</a>), up 53.2%</li>
</ul>
Companies slated to report earnings after the close include Intuitive Surgical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), Texas Instruments Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>), Capital One Financial Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>), CoStar Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSGP#NASDAQ">CSGP</a>), EQT Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQT#NYSE">EQT</a>), Enphase Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) and East West Bancorp Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NASDAQ">EWBC</a>). 
Read now:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46543934/formula-1-liberty-fwonk-stock-goldman-sachs-forecasts">Formula 1 Is Wall Street&#8217;s New Money Machine—With Horsepower </a></li>
</ul>
Image: Shutterstock

Equities

Large Cap

Broad U.S. Equity ETFs

Commodities

Economics

Tech

ETFs

$BTC

CSGP

SPDR Dow Jones Industrial Average ETF Trust

ENPH

EWBC

GOOGL

ISRG

MEDP

MSCI

PCAR

TSLA

Lockheed, General Motors Tumble, Gold Hits 1-Month Highs: What's Moving Markets Tuesday?

WIIM

Equifax shares are trading lower after the company reported Q2 financial results and issued Q3 adjusted EPS guidance below estimates.

<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="6" rowspan="1">2025 Third Quarter and Full Year Guidance</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="3" rowspan="1">Q3 2025</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="3" rowspan="1">FY 2025</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">Low-End</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">High-End</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">Low-End</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">High-End</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Reported Revenue</td>
<td colspan="1" rowspan="1">$1.505 billion</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">$1.535 billion</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">$5.970 billion</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">$6.040 billion</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Reported Revenue Growth</td>
<td colspan="1" rowspan="1">4.4&nbsp;%</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">6.5&nbsp;%</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">5.1&nbsp;%</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">6.3&nbsp;%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Local Currency Growth (1)</td>
<td colspan="1" rowspan="1">4.4&nbsp;%</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">6.5&nbsp;%</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">5.4&nbsp;%</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">6.6&nbsp;%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Organic Local Currency Growth (1)</td>
<td colspan="1" rowspan="1">4.4&nbsp;%</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">6.5&nbsp;%</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">5.4&nbsp;%</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">6.6&nbsp;%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted Earnings Per Share</td>
<td colspan="1" rowspan="1">$1.87 per share</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">$1.97 per share</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">$7.33 per share</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">$7.63 per share</td>
</tr>
</tbody>
</table>
</figure>

Guidance

Equifax Narrows FY2025 Adj EPS Guidance from $7.25-$7.65 to $7.33-$7.63 vs $7.61 Est; Raises FY2025 Sales Guidance from $5.91B-$6.03B to $5.97B-$6.04B vs $6.00B Est

Equifax Sees Q3 2025 Adj EPS $1.87-$1.97 vs $2.00 Est; Sees Sales $1.505B-$1.535B vs $1.52B Est

Earnings

Equifax Q2 2025 Adj. EPS $2.00 Beats $1.92 Estimate, Sales $1.54B Beat $1.51B Estimate

<h3>Companies Reporting Before The Bell</h3>
• PulteGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHM#NYSE">PHM</a>) is expected to report quarterly earnings at $2.97 per share on revenue of $4.40 billion. 
• RTX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) is expected to report quarterly earnings at $1.44 per share on revenue of $20.64 billion. 
• Hope Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOPE#NASDAQ">HOPE</a>) is likely to report quarterly earnings at $0.21 per share on revenue of $131.11 million. 
• General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) is likely to report quarterly earnings at $2.41 per share on revenue of $45.57 billion. 
• D.R. Horton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>) is estimated to report quarterly earnings at $2.91 per share on revenue of $8.79 billion. 
• Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) is estimated to report quarterly earnings at $2.86 per share on revenue of $5.16 billion. 
• Northrop Grumman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>) is likely to report quarterly earnings at $6.69 per share on revenue of $10.12 billion. 
• Lockheed Martin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) is likely to report quarterly earnings at $6.54 per share on revenue of $18.57 billion. 
• Invesco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVZ#NYSE">IVZ</a>) is projected to report quarterly earnings at $0.39 per share on revenue of $1.10 billion. 
• Synchrony Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYF#NYSE">SYF</a>) is estimated to report quarterly earnings at $1.71 per share on revenue of $4.03 billion. 
• Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) is projected to report quarterly earnings at $1.85 per share on revenue of $10.30 billion. 
• Complete Solaria (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPWR#NASDAQ">SPWR</a>) is projected to report quarterly loss at $0.01 per share on revenue of $85.00 million. 
• PACCAR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCAR#NASDAQ">PCAR</a>) is expected to report quarterly earnings at $1.34 per share on revenue of $6.95 billion. 
• MSCI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) is projected to report quarterly earnings at $4.12 per share on revenue of $767.15 million. 
• Old National (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONB#NASDAQ">ONB</a>) is likely to report quarterly earnings at $0.51 per share on revenue of $622.93 million. 
• The Interpublic Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPG#NYSE">IPG</a>) is expected to report quarterly earnings at $0.56 per share on revenue of $2.16 billion. 
• Halliburton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAL#NYSE">HAL</a>) is expected to report quarterly earnings at $0.56 per share on revenue of $5.43 billion. 
• Avery Dennison (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVY#NYSE">AVY</a>) is likely to report quarterly earnings at $2.41 per share on revenue of $2.23 billion. 
• MakeMyTrip (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMYT#NASDAQ">MMYT</a>) is projected to report quarterly earnings at $0.42 per share on revenue of $288.14 million. 
• Capital City Bank Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCBG#NASDAQ">CCBG</a>) is likely to report quarterly earnings at $0.80 per share on revenue of $62.25 million. 
• Valmont Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VMI#NYSE">VMI</a>) is projected to report quarterly earnings at $4.76 per share on revenue of $1.03 billion. 
• Sherwin-Williams (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHW#NYSE">SHW</a>) is projected to report quarterly earnings at $3.79 per share on revenue of $6.30 billion. 
• Pentair (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNR#NYSE">PNR</a>) is likely to report quarterly earnings at $1.33 per share on revenue of $1.11 billion. 
• Peoples Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEBO#NASDAQ">PEBO</a>) is projected to report quarterly earnings at $0.77 per share on revenue of $113.08 million. 
• Mercantile Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBWM#NASDAQ">MBWM</a>) is projected to report quarterly earnings at $1.24 per share on revenue of $60.17 million. 
• Coca-Cola (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>) is likely to report quarterly earnings at $0.83 per share on revenue of $12.57 billion. 
• KeyCorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEY#NYSE">KEY</a>) is estimated to report quarterly earnings at $0.34 per share on revenue of $1.80 billion. 
• IQVIA Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IQV#NYSE">IQV</a>) is expected to report quarterly earnings at $2.66 per share on revenue of $3.96 billion. 
• Genuine Parts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPC#NYSE">GPC</a>) is projected to report quarterly earnings at $2.07 per share on revenue of $6.11 billion. 
• Forestar Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOR#NYSE">FOR</a>) is expected to report quarterly earnings at $0.77 per share on revenue of $395.20 million. 
• First BanCorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FBP#NYSE">FBP</a>) is projected to report quarterly earnings at $0.46 per share on revenue of $251.62 million. 
• Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) is expected to report quarterly earnings at $1.92 per share on revenue of $1.51 billion. 
• Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) is expected to report quarterly earnings at $1.64 per share on revenue of $5.84 billion. 
• Quest Diagnostics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DGX#NYSE">DGX</a>) is expected to report quarterly earnings at $2.57 per share on revenue of $2.72 billion. 
• Community Financial Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBU#NYSE">CBU</a>) is expected to report quarterly earnings at $1.02 per share on revenue of $202.48 million. 
• Badger Meter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMI#NYSE">BMI</a>) is projected to report quarterly earnings at $1.22 per share on revenue of $235.90 million. 
<h3>Companies Reporting After The Bell</h3>
• Orrstown Financial Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORRF#NASDAQ">ORRF</a>) is expected to report quarterly earnings at $0.98 per share on revenue of $51.98 million. 
• Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) is expected to report quarterly earnings at $1.93 per share on revenue of $2.35 billion. 
• Core Natural Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNR#NYSE">CNR</a>) is expected to report quarterly earnings at $1.90 per share on revenue of $4.34 billion. 
• Capital One Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>) is projected to report quarterly earnings at $3.56 per share on revenue of $12.51 billion. 
• Enphase Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) is estimated to report quarterly earnings at $0.62 per share on revenue of $358.02 million. 
• Manhattan Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>) is expected to report quarterly earnings at $1.13 per share on revenue of $263.49 million. 
• PennyMac Financial Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFSI#NYSE">PFSI</a>) is projected to report quarterly earnings at $3.07 per share on revenue of $551.41 million. 
• Matador Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTDR#NYSE">MTDR</a>) is estimated to report quarterly earnings at $1.34 per share on revenue of $905.51 million. 
• Range Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RRC#NYSE">RRC</a>) is estimated to report quarterly earnings at $0.65 per share on revenue of $714.71 million. 
• Northpointe Bancshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NPB#NYSE">NPB</a>) is expected to report quarterly earnings at $0.52 per share on revenue of $57.61 million. 
• EQT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQT#NYSE">EQT</a>) is projected to report quarterly earnings at $0.43 per share on revenue of $1.78 billion. 
• Canadian National Railway (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNI#NYSE">CNI</a>) is expected to report quarterly earnings at $1.37 per share on revenue of $3.16 billion. 
• Pegasystems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGA#NASDAQ">PEGA</a>) is estimated to report quarterly earnings at $0.19 per share on revenue of $367.24 million. 
• PennyMac Mortgage IT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PMT#NYSE">PMT</a>) is projected to report quarterly earnings at $0.36 per share on revenue of $94.33 million. 
• Chubb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CB#NYSE">CB</a>) is likely to report quarterly earnings at $5.92 per share on revenue of $13.45 billion. 
• East West Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NASDAQ">EWBC</a>) is likely to report quarterly earnings at $2.23 per share on revenue of $700.82 million. 
• CoStar Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSGP#NASDAQ">CSGP</a>) is expected to report quarterly earnings at $0.10 per share on revenue of $771.82 million. 
• Karooooo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KARO#NASDAQ">KARO</a>) is projected to report quarterly earnings at $0.45 per share on revenue of $71.47 million. 
• SAP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAP#NYSE">SAP</a>) is likely to report quarterly earnings at $1.63 per share on revenue of $10.39 billion. 
• Weatherford International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WFRD#NASDAQ">WFRD</a>) is likely to report quarterly earnings at $0.98 per share on revenue of $1.19 billion. 
• Vicor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VICR#NASDAQ">VICR</a>) is projected to report quarterly earnings at $0.18 per share on revenue of $96.43 million. 
• Usana Health Sciences (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USNA#NYSE">USNA</a>) is likely to report quarterly earnings at $0.54 per share on revenue of $225.20 million. 
• Texas Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) is estimated to report quarterly earnings at $1.32 per share on revenue of $4.31 billion. 
• Trustmark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRMK#NASDAQ">TRMK</a>) is expected to report quarterly earnings at $0.86 per share on revenue of $200.74 million. 
• Renasant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNST#NYSE">RNST</a>) is projected to report quarterly earnings at $0.74 per share on revenue of $262.07 million. 
• National Bank Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NBHC#NYSE">NBHC</a>) is expected to report quarterly earnings at $0.80 per share on revenue of $109.81 million. 
• KKR Real Est Finance Tr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KREF#NYSE">KREF</a>) is projected to report quarterly loss at $0.07 per share on revenue of $31.90 million. 
• Hanmi Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAFC#NASDAQ">HAFC</a>) is likely to report quarterly earnings at $0.61 per share on revenue of $65.58 million. 
• First Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRBA#NASDAQ">FRBA</a>) is expected to report quarterly earnings at $0.42 per share on revenue of $35.27 million. 
• Cathay General (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CATY#NASDAQ">CATY</a>) is likely to report quarterly earnings at $1.10 per share on revenue of $196.36 million. 
• Cal-Maine Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) is expected to report quarterly earnings at $5.29 per share on revenue of $877.03 million. 
• First Busey (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BUSE#NASDAQ">BUSE</a>) is likely to report quarterly earnings at $0.62 per share on revenue of $193.20 million. 
• Baker Hughes (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NASDAQ">BKR</a>) is estimated to report quarterly earnings at $0.55 per share on revenue of $6.63 billion. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BUSE

CALM

CATY

CCBG

FRBA

HAFC

HOPE

KARO

KREF

MANH

MBWM

MMYT

MTDR

NBHC

ORRF

PEBO

PEGA

PFSI

RNST

SPWR

TRMK

USNA

VICR

WFRD

Earnings Scheduled For July 22, 2025

Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) will release its quarterly earnings report on Tuesday, 2025-07-22. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Equifax to report an earnings per share (EPS) of $1.92.
The market awaits Equifax's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Historical Earnings Performance</h3>
In the previous earnings release, the company beat EPS by $0.13, leading to a 1.73% increase in the share price the following trading session.
Here's a look at Equifax's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.40</td>
<td>2.10</td>
<td>1.83</td>
<td>1.73</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.53</td>
<td>2.12</td>
<td>1.85</td>
<td>1.82</td>
</tr>
<tr>
<td>Price Change %</td>
<td>2.0%</td>
<td>0.0%</td>
<td>-3.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1753110136_0.png" alt="eps graph" />
<h3>Market Performance of Equifax's Stock</h3>
Shares of Equifax were trading at $263.09 as of July 18. Over the last 52-week period, shares are down 1.24%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<h3>Analyst Views on Equifax</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Equifax.
A total of 13 analyst ratings have been received for Equifax, with the consensus rating being Outperform. The average one-year price target stands at $294.77, suggesting a potential 12.04% upside.
<h3>Analyzing Analyst Ratings Among Peers</h3>
The below comparison of the analyst ratings and average 1-year price targets of Verisk Analytics, Leidos Holdings and TransUnion, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for Verisk Analytics, with an average 1-year price target of $327.5, suggesting a potential 24.48% upside.</li>
<li>Analysts currently favor an Buy trajectory for Leidos Holdings, with an average 1-year price target of $179.2, suggesting a potential 31.89% downside.</li>
<li>Analysts currently favor an Outperform trajectory for TransUnion, with an average 1-year price target of $106.2, suggesting a potential 59.63% downside.</li>
</ul>
<h3>Insights: Peer Analysis</h3>
The peer analysis summary offers a detailed examination of key metrics for Verisk Analytics, Leidos Holdings and TransUnion, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Equifax</td>
<td>Outperform</td>
<td>3.79%</td>
<td>$785.30M</td>
<td>2.72%</td>
</tr>
<tr>
<td>Verisk Analytics</td>
<td>Neutral</td>
<td>6.96%</td>
<td>$522.20M</td>
<td>208.25%</td>
</tr>
<tr>
<td>Leidos Holdings</td>
<td>Buy</td>
<td>6.79%</td>
<td>$757M</td>
<td>8.37%</td>
</tr>
<tr>
<td>TransUnion</td>
<td>Outperform</td>
<td>7.30%</td>
<td>$650.10M</td>
<td>3.44%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Equifax ranks at the bottom for Revenue Growth among its peers. It is in the middle for Gross Profit. Equifax is at the bottom for Return on Equity.
<h3>Discovering Equifax: A Closer Look</h3>
Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States. Equifax's credit reports provide credit histories on millions of consumers, and the firm's services are critical to lenders' credit decisions. In addition, over 40% of the firm's revenue comes from workforce solutions, which provides income verification and employer human resources services. Equifax generates just over 20% of its revenue from outside the United States.
<h3>A Deep Dive into Equifax's Financials</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Growth: Equifax's revenue growth over a period of 3 months has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 3.79%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: Equifax's net margin is impressive, surpassing industry averages. With a net margin of 9.23%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Equifax's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 2.72%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Equifax's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 1.13%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 1.0, Equifax adopts a prudent financial strategy, indicating a balanced approach to debt management.
<a href="https://www.benzinga.com/quote/EFX/earnings">To track all earnings releases for Equifax visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse of Equifax's Earnings Potential

Analysts' ratings for Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) over the last quarter vary from bullish to bearish, as provided by 13 analysts.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">8</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $294.46, a high estimate of $310.00, and a low estimate of $277.00. Witnessing a positive shift, the current average has risen by 1.07% from the previous average price target of $291.33.
<img src="https://www.benzinga.com/files/images/story/2025/1752152416_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of Equifax among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ryan Griffin</td>
<td>BMO Capital</td>
<td>Announces</td>
<td>Market Perform</td>
<td>$280.00</td>
<td>-</td>
</tr>
<tr>
<td>Jason Haas</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$310.00</td>
<td>$306.00</td>
</tr>
<tr>
<td>Heather Balsky</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$285.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Mayank Tandon</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$295.00</td>
<td>$295.00</td>
</tr>
<tr>
<td>Shlomo Rosenbaum</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$295.00</td>
<td>$277.00</td>
</tr>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$300.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Toni Kaplan</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$305.00</td>
<td>$295.00</td>
</tr>
<tr>
<td>Owen Lau</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$296.00</td>
<td>$277.00</td>
</tr>
<tr>
<td>Jason Haas</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$306.00</td>
<td>$288.00</td>
</tr>
<tr>
<td>Owen Lau</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$277.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$300.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Kyle Peterson</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$295.00</td>
<td>$295.00</td>
</tr>
<tr>
<td>Jason Haas</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$284.00</td>
<td>$313.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Equifax. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Equifax compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Equifax's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Equifax's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/EFX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Equifax analyst ratings.</a>
<h2>Delving into Equifax's Background</h2>
Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States. Equifax's credit reports provide credit histories on millions of consumers, and the firm's services are critical to lenders' credit decisions. In addition, over 40% of the firm's revenue comes from workforce solutions, which provides income verification and employer human resources services. Equifax generates just over 20% of its revenue from outside the United States.
<h3>A Deep Dive into Equifax's Financials</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Growth: Equifax's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 3.79%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Net Margin: Equifax's net margin excels beyond industry benchmarks, reaching 9.23%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Equifax's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 2.72%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Equifax's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 1.13%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Equifax's debt-to-equity ratio is below the industry average at 1.0, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Significance of Analyst Ratings Explained</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Expectations For Equifax's Future

BMO Capital analyst Ryan Griffin initiates coverage on Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Market Perform rating and announces Price Target of $280.

Initiation

BMO Capital Initiates Coverage On Equifax with Market Perform Rating, Announces Price Target of $280

<a href="https://x.com/pulte/status/1942665475516674342" title="https://x.com/pulte/status/1942665475516674342">https://x.com/pulte/status/1942665475516674342</a>

FICO

U.S. Director of Federal Housing Pulte Posts On X "We will be incentivizing lenders, who USE both Vantage 4.0 and FICO, with better pricing - anything to help the consumer."

<a href="https://x.com/pulte/status/1942589271702962447" title="https://x.com/pulte/status/1942589271702962447">https://x.com/pulte/status/1942589271702962447</a>

FMCC

FNMA

U.S. Director of Federal Housing Pulte Posts On X "Effective today, to increase competition to the Credit Score Ecosystem and consistent with President Trump's landslide mandate to lower costs, Fannie and Freddie will ALLOW lenders to use Vantage 4.0 Score with no current requirement to build new infrastructure (stays Tri Merge)."

Wells Fargo analyst Jason Haas maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Overweight and raises the price target from $306 to $310.

Wells Fargo Maintains Overweight on Equifax, Raises Price Target to $310

Press Releases

Equifax Redesigns U.S. Consumer Credit Report to Help Consumers More Easily Monitor Financial Health

General

Debt Pressure Building Up for Canadian Businesses

Fintech

Equifax Announces Agenda for 2025 Investor Day on June 17

Equifax Introduces Optimal Path™ Interactive Score Planner

Equifax Secures 35 New Patents, Advancing Responsible AI, Machine Learning, and Fraud & Identity Solutions

Equifax Introduces Complete Income™ for Social Services

NYSE Content Advisory: Pre-Market update + ICE begins trading on NYSE Texas

New Survey from Kompliant and Equifax Highlights the Importance of Advanced Compliance Technology in Maintaining a Competitive Advantage

Equifax Announces Earnings Release Date and Conference Call for Second Quarter 2025 Results

Equifax Delivers Above Guidance Second Quarter Results; Returns Approximately $190 Million Cash to Shareholders

Comments

Equifax

Noticias

Últimas noticias sobre Equifax (NYSE:EFX) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL